Skip to main content

Reviewers of the Quarter

Lipids in Health and Disease is pleased to implement a new platform of recognition every quarter, for the peer reviewers who provided the best performance along these parameters:

  • Accepting the reviewer invitation (acceptance rate)
  • Scrutinizing peer review
  • Completion
  • Accepted-Completion %
  • On time delivery-Completion %
  • Editor-in-Chief evaluation rate

The journal cannot succeed without its peer reviewers, and we thank the hard-working members of our network.

Second Quarter of 2020

New Content ItemIoannis Bellos
Sotiria General Hospital of Chest Diseases, Athens, Greece; 
National and Kapodistrian University of Athens, Greece

Ioannis works as a resident physician of Internal Medicine at "Sotiria" General Hospital of Chest Diseases and is also a research fellow at National and Kapodistrian University of Athens, Greece. Clinical interests are in the areas of nephrology and cardiovascular disease. Ionnis's research areas of interest include clinical epidemiology, evidence synthesis, and methodology of systematic reviews. Ionnis is particularly interested in network meta-analyses aiming to answer questions about clinical decisions in the fields of hypertension and metabolism.

New Content ItemAmany Mousa
Cairo University, Egypt

Amany has been a Professor Emeritus in the Faculty of Graduate Studies for Statistical Research, Cairo University, since 2008. Granted a Ph.D, in statistics from the University of Florida in 1981, Amany has worked in a number of international universities (including the University of Florida, University of Georgia, Cairo University-Khartoum Branch, King Saud University, Riyadh, and local Egyptian universities). Amany has also been a supervisor and arbitrator of dozens of Master and doctorate theses.

First Quarter of 2020

Federica Fogacci
University of Bologna, Bologna, Italy

New Content ItemFederica is a meta-analyst and member of the Brisighella Heart Study Group and investigator for several clinical trials in nutraceuticals, in accordance with the principles of ICH GCP Guidelines. She has authored more than 65 full scientific papers published in international peer-reviewed journals. She is a reviewer of papers for several high-quality scientific journals in the fields of internal medicine, cardiovascular disease prevention, metabolic diseases, nutrition/nutraceuticals, and pharmacotherapy. She is a member of the American Society For Preventive Cardiology (ASPV), the American Society for Nutrition (ASN), the European Society of Hypertension (ESH), and the Italian Society for the Study ofAtherosclerosis (SISA).

Xianbin Zhang
Shenzhen University General Hospital, China

New Content ItemXianbin Zhang is currently a post doctor in the Department of General Surgery, Shenzhen University General Hospital. He obtained his MD at Rostock University and the classification (mit dem Pr├Ądikat) of his dissertation is magna cum laude. Dr. Xianbin Zhang focuses on the basic research and the clinical translation of pancreatic cancer. He currently published more than 30 publications and these publications have accumulated over 100 citations.

Featured article: Role of non-statin lipid-lowering therapy in coronary atherosclerosis regression

New Content Item (1)Several studies have investigated the association between non-statin lipid-lowering therapy and regression of atherosclerosis. However, these studies were mostly small and their results were not always robust. Our authors objectives were: (1) to define if a dual lipid-lowering therapy (statin + non-statin drugs) is associated with coronary atherosclerosis regression, estimated by intravascular ultrasound (IVUS); (2) to assess the association between dual lipid-lowering-induced changes in low density lipoprotein cholesterol (LDL-C) and non-high-density-lipoprotein cholesterol (non-HDL-C) levels and atherosclerosis regression.

Annual Journal Metrics